Defence Closes Second Tranche of Fully Subscribed Financing Totaling $4.2 Million
Montreal, Quebec--(Newsfile Corp - January 31, 2025) - Defence Therapeutics Inc (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing...